You have 9 free searches left this month | for more free features.

revlimid

Showing 1 - 20 of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)

Terminated
  • Chronic Lymphocytic Leukemia(CLL)
  • Small Lymphocytic Lymphoma
  • Hackensack, New Jersey
    Hackensack University Medical Center
Jun 24, 2022

Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the NCI (obinutuzumab, prednisone, Revlimid)

Recruiting
  • Lymphoma
  • +3 more
  • obinutuzumab
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Chronic Lymphocytic Leukemia, CLL Trial in La Jolla (Revlimid, Rituximab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • CLL
  • La Jolla, California
    University of California, San Diego
Sep 2, 2021

Multiple Myeloma Trial in Taipei (Revlimid)

Completed
  • Multiple Myeloma
  • Revlimid
  • Taipei, Taiwan
    NTUH
Nov 14, 2019

Prostate Cancer Trial in Baltimore (Revlimid)

Completed
  • Prostate Cancer
  • Revlimid
  • Baltimore, Maryland
    The Harry and Jeanette Weinberg Building
Apr 11, 2019

Follicular Lymphoma Trial in Shanghai (Revlimid)

Unknown status
  • Follicular Lymphoma
  • Revlimid
  • Shanghai, Shanghai, China
    Ruijin Hospital
Jul 4, 2019

Multiple Myeloma Trial in United States (Revlimid, Velcade, dexamethasone)

Terminated
  • Multiple Myeloma
  • Revlimid
  • +3 more
  • Los Angeles, California
  • +4 more
Jun 26, 2018

Multiple Myeloma Trial in Durham (Velcade, Cyclophosphamide, Revlimid)

Terminated
  • Multiple Myeloma
  • Durham, North Carolina
    Duke University Medical Center
Apr 26, 2017

Melanoma Trial run by the NCI (Revlimid)

Completed
  • Melanoma
  • Revlimid
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Nov 14, 2016

Waldenstrom Macroglobulinemia Trial in France (Revlimid)

Completed
  • Waldenstrom Macroglobulinemia
  • Revlimid
  • Bayonne, France
  • +6 more
Jun 6, 2017

Multiple Myeloma Trial in Spain (Melphalan, Prednisone, Velcade)

Completed
  • Multiple Myeloma
  • Palma de Mallorca, Baleares, Spain
  • +62 more
Jan 16, 2017

Multiple Myeloma Trial in Stockholm (Revlimid)

Completed
  • Multiple Myeloma
  • Revlimid
  • Stockholm, Sweden
  • +1 more
Mar 24, 2016

Multiple Myeloma Trial in Little Rock (Revlimid)

Completed
  • Multiple Myeloma
  • Revlimid
  • Little Rock, Arkansas
    University of Arkansas for Medical Science-MIRT
Sep 29, 2015

Acute Myeloid Leukemia Trial in Toronto (Revlimid)

Completed
  • Acute Myeloid Leukemia
  • Revlimid
  • Toronto, Ontario, Canada
    University Health Network, Princess Margaret Hospital
Jun 17, 2015

Pancreatic Carcinoma Metastatic, Pancreatic Ductal Adenocarcinoma Trial in Stockholm (Gemzar, Revlimid)

Completed
  • Pancreatic Carcinoma.
  • Stockholm, Solna, Sweden
    Karolinska University Hospital
Nov 26, 2014

Chronic Myelomonocytic Leukemia Trial in Austria (Revlimid)

Unknown status
  • Chronic Myelomonocytic Leukemia
  • Revlimid
  • Linz, Oberösterreich, Austria
  • +9 more
Mar 6, 2015

Prostate Cancer Trial in Niles, Park Ridge (Revlimid)

Completed
  • Prostate Cancer
  • Revlimid
  • Niles, Illinois
  • +1 more
Feb 28, 2014

Diffuse Large B-cell Lymphoma. Trial in Hackensack, Durham (Revlimid)

Unknown status
  • Diffuse Large B-cell Lymphoma.
  • Revlimid
  • Hackensack, New Jersey
  • +1 more
Feb 2, 2014

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Revlimid)

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Revlimid
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 5, 2013

Relapse, Refractory Multiple Myeloma Trial in Wuerzburg (Revlimid)

Completed
  • Relapse
  • Refractory Multiple Myeloma
  • Revlimid
  • Wuerzburg, Bavaria, Germany
    Dept. of Internal Medicine II, University of Wuerzburg
Aug 3, 2009